Current T-cell epitope prediction tools are a valuable resource in designing targeted immunogenicity 29 experiments. They typically focus on, and are able to, accurately predict peptide binding and presentation by 30 major histocompatibility complex (MHC) molecules on the surface of antigen-presenting cells. However, 31 recognition of the peptide-MHC complex by a T-cell receptor is often not included in these tools. We developed 32 a classification approach based on random forest classifiers to predict recognition of a peptide by a T-cell and 33 discover patterns that contribute to recognition. We considered two approaches to solve this problem: (1) 34 distinguishing between two sets of T-cell receptors that each bind to a known peptide and (2) retrieving T-cell 35 receptors that bind to a given peptide from a large pool of T-cell receptors. Evaluation of the models on two 36 HIV-1, B*08-restricted epitopes reveals good performance and hints towards structural CDR3 features that can 37 determine peptide immunogenicity. These results are of particularly importance as they show that prediction of 38 T-cell epitope and T-cell epitope recognition based on sequence data is a feasible approach. In addition, the 39 validity of our models not only serves as a proof of concept for the prediction of immunogenic T-cell epitopes 40 but also paves the way for more general and high performing models.
Introduction

42
Immunoinformatics strives to computationally explore the increasingly large amounts of available 43 immunological data by providing researchers with the necessary tools to gain novel insights into key processes 44 of the immune system. The necessity of such immunoinformatics tools becomes particularly apparent in light of 45 the huge complexity that underlies essential immunological processes. As the immune system has to be able to 46 recognize a vast repertoire of non-self epitopes, it has adopted several strategies to cope with the wide range of 47 pathogens and pathogen-derived epitopes it might come into contact with. To mount an adequate defence, the 48 activation of the adaptive immune system requires recognition of these pathogen-derived epitopes by TCRs. 
57
Both antigen processing and presentation by MHC molecules are well-studied processes and have been 58 documented in detail for both MHC class I and MHC class II molecules. A range of immunoinformatics tools 59 have addressed the fundamental question of which peptides will be presented by a certain MHC molecule (Soria-60 Guerra et al. 2015) . Several of these tools are able to predict putative epitopes with high accuracy. Furthermore, 61 they often account for biologically relevant pre-processing steps such as proteasomal cleavage of proteins and 62 transport of peptides into the endoplasmic reticulum by TAP transporters (Stranzl et al. 2010 ). Despite the 63 diversity of possible pMHC combinations, these tools offer researchers a reliable way of setting up focused 64 immunogenicity experiments by reducing the number of peptides that need to be experimentally tested (7-11).
65
The success of these prediction tools stems from both our intimate understanding of the underlying biochemical 66 processes as well as from the large amounts of pMHC affinity data that are available in public repositories such 67 as the Immune Epitope Database (www.iedb.org) (Vita et al. 2015) . However, it is important to note that while it 68 is required that immunogenic peptides are presented to T-cells by an MHC molecule, this is not sufficient to 69 warrant recognition by a TCR and subsequently elicit an immune response. Although these pMHC prediction 70 methods claim to predict T-cell epitopes, they do so without any knowledge or contribution from the T-cell 71 4 repertoire. These prediction tools are mainly able to differentiate between MHC-bound peptides, which could 72 potentially be recognized by a TCR, and those peptides that are not bound by the specific MHC molecule under 73 investigation. However, no such prediction tools exist for TCR-sequences and a given MHC-bound peptide and 74 it is a concern if such predictions are even possible given the complexity of the recognition and the lower 75 quantity of data.
76
Previous research has demonstrated that there is a differential contribution of the amino acid position in the 77 epitope to its immunogenicity (Calis et al. 2013). As the CDR3 region of the TCR is known to interact with the 78 MHC presented peptide (Jorgensen et al. 1992) , it is to be expected that structural determinants within this 79 region also contribute significantly to peptide recognition. In this study, we demonstrate the feasibility of 80 constructing accurate TCR-epitope recognition predictors based on the amino acid sequence of the TCR protein.
81
We explore the patterns underlying the interaction between peptides and TCRs, focusing on those patterns within 82 the CDR3 region that determine epitope recognition.
83
5
Results
84
Data on peptide-TCR interactions was collected from Costa et al. (2015) for two well-defined and dominant 85 HLA-B*08-restricted HIV-1 epitopes. Control data, consisting of CD8+, HLA-B*08-restricted TCRβ sequences, 86 was retrieved from the ImmuneACCESS database. For each dataset, the following descriptive statistics were 87 calculated: total number of TCRβ sequences, unique CDR3 sequences, V/J families and V/J genes and the 88 Shannon-Wiener diversity of CDR3 sequences, V/J families and V/J genes (table 1) . Higher Shannon-Wiener 89 diversity values reflect a more uniform population and/or a population with more unique samples. CDR3 90 sequences are the most diverse component in all datasets, followed by V gene diversity, J gene diversity, V 91 family diversity and finally J family diversity. While the majority of CDR3 sequences that occur in a given 92 dataset are unique, some CDR3 sequences do frequently reoccur, though the number of reoccurring CDR3 93 sequences is several orders of magnitudes lower. The negative control set is always the most diverse when 94 comparing diversity between datasets, except for J family diversity, where the usage is slightly more uniformly 95 spread across the data for the negative control TCRs than the epitope-specific TCRs. These results indicate a 96 slightly restricted diversity of the epitope-specific TCR datasets when compared to the negative control set 97 (figure 1).
98
A highly performant classifier to distinguish two target epitopes 99 To test whether it is feasible to predict binding between a CD8+ T-cell's TCRß and an epitope, we first tested a 100 'one-versus-one', random forest classifier scheme where the classifier attempts to predict which of the two HIV 101 epitopes a TCR sequence is most likely to be bound in a mutually exclusive way. The input features were 102 derived from the V and J genes as well as the CDR3 sequence of the ß chain of the TCR. The performance of 103 this classifier was evaluated within a repeated subsampling validation approach in which part of the data is used 104 as an independent test set for the trained classifier. This validation showed that the average classifier had a mean 105 accuracy of 75.90% ± 5.45%, a mean AUC of 0.84 ± 0.05 and a mean PR of 0.81 ± 0.06 (FLKEKGGL) and 0.89 106 ± 0.04 (EIYKRWII) on independent test data. The high accuracy indicates that, in general, there is a high rate of 107 both true positives and true negatives; in essence, the classifier is able to correctly assign to which peptide a 108 given TCR will bind. As AUC values range from 1 (perfect prediction) to 0 (completely wrong prediction), with 109 a value of 0.5 representing completely randomly assigned labels, the resulting average AUC value demonstrates 110 that the classifier performs significantly better than random (one sample t-test; p < 0.001) ( figure 2a ). Finally, the 111 mean PR, ranging between 0 (no true positives among predicted positives) and 1 (only true positives among 6 predicted positives), demonstrates that the averaged classifier is able to retain a high predictive quality even 113 under increasing numbers of predicted positives (figure 2b, 2c).
114
Features with high discriminatory power within the classifier can be supposed to play prominent roles within the 115 biological recognition process between peptide and TCR. We thus investigated which features were most 
124
Epitope-specific TCRs can be picked out of a large TCR background 125 Evaluation of the 'one-versus-one' classifier scheme shows that differentiating between two peptides based on 126 TCRβ sequence derived features is a feasible task. However, the scope of such a classifier remains limited in its 127 applicability. To explore to which extend TCRβ sequence information can support sequence based TCR epitope 128 predictors, we generalized the problem to identifying TCRβs that bind a given peptide from a larger set of 129 TCRβs. This 'one-versus-many' scheme was applied and tested for both the FLKEKGGL and EIYKRWII 130 peptide using non-epitope specific HLA-B*08-restricted, CD8+ TCR sequences as a negative control. While it is 131 not known whether any of these control T-cell receptor sequences are capable of recognizing either B*08-132 FLKEKGGL or B*08-EIYKRWII, the upper limit of the expected abundance of T-cells that recognize a specific 133 HLA-peptide combination has been estimated at 100 cells per million naïve T-cells (Jenkins and Moon 2012).
134
As such, we assume that very few to none of these TCRßs are capable of interacting in a functionally relevant 135 way with either of two HIV epitopes.
136
On the FLKEKGGL as well as the EIYKRWII peptide, the same pipeline was applied. TCRβ sequence features 137 were generated in the same way as in the 'one-versus-one' classifier scheme. The performance of a classifier 138 trained following the 'one-versus-many' scheme was evaluated within a repeated subsampling validation 139 approach. Evaluation of the classifier revealed a mean accuracy of 93.78% ± 0.66%, a mean AUC of 0.80 ± 0.05 140 and a mean PR of 0.52 ± 0.06 for the EIYKRWII peptide. For the FLKEKGGL peptide, a mean accuracy of 141 94.45% ± 0.72%, a mean AUC 0.82 ± 0.05 of and a mean PR 0.61 ± 0.07 of were obtained. Evaluation metrics 7 again indicate that both classifiers perform significantly better than random based on the AUC value (p < 0.001 143 for both the EIYKRWII and FLKEKGGL peptide) (figure 3a, 3b) and reach similar performance levels as the 144 'one-versus-one' approach. The accuracy seemingly increases for the 'one-versus-many' classifiers as a 145 consequence of class imbalance in the dataset (10 negative cases for every positive case) and is thus only 146 marginally higher than the base accuracy of 0.91. PR values drop rapidly in comparison to the 'one-versus-one' 147 scheme, likely also due to the class imbalance ( figure 3c, 3d ). With a higher number of negative classes, it 148 becomes increasingly more difficult to retain a high predictive quality of the positive class and a low number of 149 false positive predictions already severely affects precision. Given the increased complexity of the task, the 150 slight drop in performance of the 'one-versus-many' classifiers is not completely unexpected. However, 'one-151 versus-many' classifiers are able to retain a high level performance level and reinforce the feasibility of creating 152 more complex TCR epitope predictors. Differences in performance between the two 'one-versus-many' 
171
More TCR training samples result in a more performant classifier 8 Finally, to investigate the influence of the size of the training data on the performance both the 'one-versus-one' 173 and 'one-versus-many' classifiers, models were trained with and without independent test data on increasing 174 training data sizes. Regardless of the size of the training data, classifiers always performed with perfect accuracy 175 if no independent test data was used, as can be expected from classification frameworks ( figure 4, 5) . In contrast, 176 classifiers with independent test data benefited from increases in training data size and are likely to improve 177 even further given a sufficiently large body of training data. As such, at least within the context of these 178 classification schemes, the performance is likely to benefit from increases in experimental data.
9
Discussion
180
In this paper, we set out to examine the feasibility of predicting epitope specificity from the sequence patterns 181 contained within the TCR. Based on training data collected for 2 HIV-1 derived, B*08-restricted peptides, we 182 trained random forest classifiers utilizing two different schemes to test whether TCR epitope prediction based on 183 sequence level data is a feasible task. In the first, 'one-versus-one', scheme, the classifier was tasked to assign 184 TCRs to either of two possible peptides. In the second, 'one-versus-many', scheme, classifiers were trained to 185 find TCRs that bind to one specific peptide. In order to examine the properties that define the recognition of 186 immunogenic peptides by a TCR, structural features were encoded representing the CDR3 amino acid sequence 187 of the TCR ß-chain as well as its respective V and J region.
188
As this is, to the best of our knowledge, the first attempt to tackle this problem at the TCR sequence level, it is 189 not possible to compare its performance with other pre-existing classifiers. However, multiple performance 190 evaluations indicate that the different classifiers performed reasonably well. The best performing scheme was the 191 'one-versus-one' scheme. However, the applications of this one-versus-one classifier are limited as it can only 192 distinguish between the TCR sequences that bind one of two epitopes. Indeed, the importance of this classifier 193 lies not in its immediate practical applicability, but rather in the framework it provides for future TCR-peptide 194 recognition models and the insights that might be gained from these models. We can suppose that, given enough 195 data for a large number of epitopes, this binary classifier can be expanded into a framework to predict the target 196 epitope for any TCR sequence.
197
To demonstrate a more practical application, we incorporated negative control data from a large set of HLA-198 B*08-restricted TCRβs into 'one-versus-many' classification schemes. During these more difficult 'one-versus-199 many' classification schemes, performance was still high enough to prove that sequence level based models are 
217
Although the immediate applicability of the binary, 'one-versus-one' peptide classifier is limited in scope, its 218 good performance illustrates the feasibility of creating high-performing p-TCR affinity models. We further 219 demonstrate this feasibility by creating random forest classifiers that can distinguish TCRs that bind a specific 220 epitope. Next to the binary classifier, these more general 'one-versus-many' classifier schemes set the stage for 221 the development of more complex TCR prediction models in the future. Despite only using sequence 222 information for the TCR ß-chain, classifiers were able to differentiate their targeted epitope with high accuracy.
223
In addition, the classifiers agree on highly discriminatory features, even for different classifiers contexts and are 224 thus likely able to uncover important structural features. Thus it seems that the recognition determinants 225 contained within the ß-chain are already sufficient to predict epitope binding. These results do still leave room 226 for increased performance. Indeed, learning curves for the different classifier schemes suggests that performance 227 increases can still be gained by incorporating new training data. These results indicate that current models are 228 therefore not necessarily bound by technical limitations but rather by a lack of suitable training data. As we 229 anticipate the amount of available MHC-peptide-TCR data to increase in the future, we expect sequence based 230 models to quickly gain in performance and become a valuable aid in future immunological studies. In particular, 231 insights and advancements into TCR recognition of immunogenic epitopes might prove crucial in studies of 232 auto-immunity, tumour susceptibility and vaccine design. TCR, a 'one-versus-one' scheme and a 'one-versus-many' scheme were employed. In the 'one-versus-one' 274 scheme, the classifier was tasked with correctly assigning whether a TCR binds to either the EIYKRWII peptide 275 or the FLKEKGGL peptide. In the 'one-versus-many' scheme, the classifier had to distinguish between TCRs 276 that bind a given peptide and TCRs that don't bind the given peptide. The 'one-versus-many' scheme was 277 applied for both the EIYKRWII and the FLKEKGGL peptide.
278
During the 'one-versus-one' scheme, both the positive and negative class samples were considered to be of equal 279 importance and their weight was set at 1. For the 'one-versus-many' scheme, class weights were set to be 
306
Classifiers with independent test data used a stratification and sampling scheme as described above for their 307 respective schemes while classifiers without independent test data were tested on their training data.
308
All data and code used within this manuscript can be found in the following GitHub repository: 
